| Variables | Skin irritation | ||
| Yes N = 11 | No N = 14 | P-value* | |
| Central line-associated bloodstream infection, % (n) |
|
| 0.68 |
| Catheter present infection occurrence | 16.0 (4) | 16.0 (4) |
|
| Catheter absent infection occurrence | 28.0 (7) | 40.0 (10) |
|
| Type of HSCT, % (n) |
|
| 0.03 |
| Allogenic | 32.0 (8) | 16.0 (4) |
|
| Autologous | 12.0 (3) | 40.0 (10) |
|
| Type of catheter, % (n) |
|
| 0.67 |
| Tunneled CVC | 32.0 (8) | 20.0 (5) |
|
| Non-tunneled CVC | 12.0 (3) | 36.0 (9) |
|
| Catheter time in place, % (n) |
|
| 0.67 |
| Less than 20 days | 12.0 (3) | 36.0 (9) |
|
| More than 20 days | 32.0 (8) | 20.0 (5) |
|
| Type of chemotherapy conditioning regimens, % (n) |
|
| 0.88 |
| Low intensity | 16.0 (4) | 16.0 (4) |
|
| Medium intensity | 4.0 (1) | 8.0 (2) |
|
| High intensity | 24.0 (6) | 32.0 (8) |
|